Financials

  • Market Capitalization 5.68 M
  • Employee 1
  • Founded 2020
  • CEO N/A
  • Website liminatuspharma.com
  • Headquarter Delaware, United States
  • FIGI BBG01HVYG111
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
4894
PCSA
Processa Pharmaceuticals, Inc. - Common Stock
2.06 USD-3.29%-2.37%+7.85%-7.41%5.75 M USD
4898
BGMS
Bio Green Med Solution, Inc. - Common Stock
0.86 USD-3.37%-2.27%-1.15%-85.67%5.70 M USD
4901
BTAI
BioXcel Therapeutics, Inc. - Common Stock
0.18 USD-75.00%-77.50%-77.22%-88.61%5.63 M USD
4909
PMCB
PharmaCyte Biotech, Inc. - Common Stock
0.52 USD-3.70%-1.89%-11.86%-48.00%5.58 M USD